Skip to main content

Multi-omics and Biomarkers

Edited by:

Mi-Die Xu, MD, PhD, Fudan University Shanghai Cancer Hospital, China

Submission Status: Open   |   Submission Deadline: 31 October 2025 


Biomarker Research is calling for submissions to our Collection on 'Multi-omics and Biomarkers.' 

This collection aims to explore innovative methodologies and applications in integrating multi-omics data to identify and validate biomarkers.

About the Collection

Biomarker Research is calling for submissions to our Collection on 'Multi-omics and Biomarkers.' This collection aims to explore innovative methodologies and applications in integrating multi-omics data to identify and validate biomarkers. Topics of interest include, but are not limited to, integrative analysis techniques, computational tools, and studies demonstrating clinical relevance. 

Submissions should provide novel insights or comprehensive reviews that advance the field. Join us in contributing to this cutting-edge area of biomarker research. Manuscripts will undergo rigorous peer review to ensure high-quality contributions.


Image credit: © [M] ArtemisDiana / stock.adobe.com

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles and Reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Multi-omics and Biomarkers" under the “Details” tab during the submission stage. Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editor has no competing interests with the submissions which are handled through the peer-review process. The peer-review of any submissions for which the Editor has competing interests is handled by another Editorial Board Member who has no competing interests.